Navigation Links
Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever
Date:11/15/2009

Nutra Pharma has announced its intention to begin the drug registration process in Brazil and Colombia for its over-the-counter pain reliever. The company is currently marketing a similar analgesic, Cobroxin, in the United States for the treatment of moderate to severe (Stage 2) chronic pain.

Plantation, FL (Vocus) November 15, 2009 -- Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it plans to begin the drug registration process in Brazil and Colombia for its over-the-counter (OTC) pain reliever. The company is currently marketing a similar drug in the United States under the brand name Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain.

“Beginning the drug registration process in Brazil and Colombia offers us the opportunity to introduce our over-the-counter pain reliever into countries that have significant portions of their populations suffering from chronic pain, but lack sufficient access to opioid-based analgesics,” explained Dr. Paul Reid, CEO of ReceptoPharm. “We have already begun conversations with potential South American licensees and plan to initiate the drug registration process in both countries as we move into 2010,” he added.

Nutra Pharma introduced a similar pain medicine in the United States in August under the br
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Vivakor Presents at Nutraceutical Event
2. Reportlinker Adds US World Nutraceutical Ingredients Industry
3. RZN Nutraceuticals Receives United States Patent & Trademark Office Notice of Allowance for Proprietary HerbaZorb(TM) Absorption and Delivery System Technology Used in Popular Arthri-Zen Relief(R) and Migra-Zen Relief PLUS(R) Products
4. Star Scientific Files Second Quarter Financial Results; Rock Creek Pharmaceuticals Reports Early Promising Results in Studies Assessing Safety and Viability of Active Components for a Non-Nicotine Nutraceutical (CigRx(TM))
5. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
6. NutraCea Announces Additions to Management Team; Chief Operating Officer Extends Employment Contract
7. Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program
8. HBA X-Ceuticals Conference Explores The Emerging Market of Cosmeceuticals and Nutraceuticals
9. Nutrition 21 Launches New Innovative PRESCRIPTIX(TM) Nutraceuticals Product Line
10. Synutra Annual Report on Form 10-K Includes Going Concern Explanatory Paragraph from Auditor
11. Synutra International, Inc. Sets the Date for its Fourth Quarter and Fiscal Year Earnings Announcement
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever
(Date:12/22/2014)... Petersburg, FL (PRWEB) December 22, 2014 Christmas ... Sublime Beauty® has a fast and easy solution that will ... gift cards can be purchased from from $25 up to ... "We offer 100% customer satisfaction and a wide array of ... have no fees and no expiration dates. , Gift ...
(Date:12/22/2014)... City, NY (PRWEB) December 22, 2014 ... as a 2014 Professional Woman of the Year. She ... healthcare. As the largest, most recognized networking organization of ... and profession, the National Association of Professional Women is ... nearly 300 Local Chapters. , Ms. Kreider is passionate ...
(Date:12/22/2014)... The NLN’s 2015 Leadership ... this month. Faculty have been selected through competitive ... fast-tracked for administrative leadership roles within their academic ... Simulation Educators, featuring a curriculum uniquely devised for ... , Twenty nurse educators were chosen for ...
(Date:12/22/2014)... Parker & Sons, Inc. a reliable and ... contracting services reports a record number of favorable reviews ... 2014. As a company that has served the greater ... Sons is a business that is focused on excellent ... other top quality companies in Arizona that are focused ...
(Date:12/21/2014)... Recently, BambooFlooringChina.com, a famous bamboo lumber supplier, has ... and launched a bamboo flooring promotion with great discounts, ... 30, 2015. , According to the CEO of the ... available today; it has a highly distinctive grain with ... woven bamboo is made by a unique manufacturing process ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Cheryl A. Kreider, President / CEO of Kreider Health Solutions, LLC, a 2014 Professional Woman of the Year 2Health News:NLN Leadership Institute Announces 2015 Cohorts 2Health News:NLN Leadership Institute Announces 2015 Cohorts 3Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 2Health News:Parker & Sons Reports A Record Number Of Favorable References With Regard To Its Quality Services In 2014 3Health News:BambooFlooringChina.com Announced Its Durable Strand Woven Bamboo Flooring Collection 2
... people who are into substance abuse.// This was the ... Institute on Drug Abuse, US, and others after taking ... disorder is a form of psychiatric condition that is ... violate the rights of others. Often people with antisocial ...
... People suffering from diabetes type 1 or type 2 ... tract infections and skin infections. ,Some other ... kidney damage, nerve damage, eye problems that can lead ... a major risk factor for incidence of diabetes of ...
... recurrence of thyroid cancer may be detectable using a ... according to a study published by researchers at ... Arthur G. James Cancer Hospital and Richard J. Solove ... online in the Journal of Clinical Endocrinology & Metabolism. ...
... number of vaginal cancer and cancerous lymph//nodes than CT ... Washington University School of Medicine in St. Louis. An ... of the ‘International Journal of Radiation Oncology, Biology, Physics’ ... early detection of cancers of this region. According to ...
... in their mother’s womb can be an indication of how ... ,Polycystic ovarian syndrome is a condition that affects about ... is characterized by high levels of male hormones called androgens, ... absence of small cysts in their ovaries. The syndrome may ...
... can now help the clinicians to predict which wounds like ... known as pressure sores or pressure ulcers, affect people mostly ... or at home without much movements. Bedsores arise from poor ... About 5-10% of the total patients in the institutionalized health ...
Cached Medicine News:Health News:Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available 2Health News:PET Scanner detects more Vaginal cancer than CT scans 2
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation ... focused on discovering, developing and commercializing innovative therapies ... today issued the following open letter to shareholders ... Dr. Med. Sc. Dear RXi Shareholders, ... number of inaccurate statements posted on certain social ...
(Date:12/22/2014)... , Dec. 22, 2014  Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced ... been dosed in a pharmacokinetic and pharmacodynamic study ... for neuropathic pain. Racemic methadone is ... various pain states and substitution therapy in opioid ...
(Date:12/19/2014)... Calif. , Dec. 19, 2014  Newport ... that Siddhartha Kadia, Ph.D. has joined the company,s ... Chief Executive Officer and a director of Evans ... laboratory testing, evaluation and analytical services to companies ... Prior to joining Evans Analytical Group, Dr. ...
Breaking Medicine Technology:RXi Pharmaceuticals Issues Open Letter to Shareholders 2RXi Pharmaceuticals Issues Open Letter to Shareholders 3RXi Pharmaceuticals Issues Open Letter to Shareholders 4RXi Pharmaceuticals Issues Open Letter to Shareholders 5RXi Pharmaceuticals Issues Open Letter to Shareholders 6Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 2Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone 3Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2
... Biopharmaceutical Company Kiadis Pharma announced today that it has received ... US Food and Drug Administration (FDA) to start the pivotal ... the United States .  Kiadis Pharma is currently enrolling patients ... Europe and Canada .  With the approval of ...
... July 8 K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company") ... ("NYSE") on June 30, 2010 informing the Company that ... the NYSE,s Listed Company Manual ("Section 802.01E") as the result of ... for its fiscal year ended March 31, 2010 (the ...
Cached Medicine Technology:Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States 2Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States 3K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010 2K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010 3K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010 4K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010 5K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010 6K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010 7K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010 8
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
... Medtronic Ophthalmics offers the most ... specialty Eraser Instruments for Cataract incision, ... and discrete coagulation is achieved with ... cellular necrosis. Straight eraser styles are ...
Medicine Products: